The present survey is part of the EU funded project EMAPS-CARDIO (ID:
953138, www.emaps-cardio.eu) that is developing a new platform for growth and maturation of cardiac microtissues for adult-like organotypic models. The project aims at
To reach the above goals, we invite you to answer
five groups of questions: In particular, the first group will identify
your background in the organ-on-chip technology. Your personal data will be used only for the purposes of the present questionnaire and in full compliance with GDPR rules. The second group will establish the
key functions of the technology in a variety of market segments. The third group will determine the
"obligatory", market-specific properties of the technology. The fourth group will describe the technology by its
design and technical properties; and the last group will identify the relevant
environmental and social properties of the technology. We intend to distribute our questionnaire to a wide range of stakeholder groups, thus identifying conflicting
interests and potential impacts along the value chain.
Your answers will be extremely useful and greatly appreciated.
Thank you very much for your contribution.
The BIOT team
